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This Month in the Journal
The extent of linkage disequilibrium varies widely be-
tween chromosomal regions and between populations.
This month in the Journal, Jonathan Pritchard and
Molly Przeworski contribute a review that addresses
these differences, from both a modeling and an empirical
standpoint (p. 1). They also discuss how the extent of
linkage disequilibrium affects association and fine-map-
ping studies. In another review, Pragna Patel and Grazia
Isaya (p. 15) provide an overview of Friedreich ataxia,
including (a) possible mechanisms by which the GAA
triplet-repeat expansion interferes with transcription of
the FRDA gene, (b) the normal role of the frataxin pro-
tein, (c) the pathogenesis of this disorder, and (d) mouse
models of Friedreich ataxia.
USH1F Caused by PCDH15 Mutations, by Ahmed et
al. (p. 25)
Using three families with Usher syndrome type 1F
(USH1F), which is characterized by profound congen-
ital deafness and retinitis pigmentosa, Ahmed et al. were
able to limit the USH1F locus to 1 Mb on chromosome
10q21.1. A mouse chromosomal region that is syntenic
to the USH1F locus contains Pcdh15, a gene that is
mutated in the deaf Ames waltzer mouse. Therefore, the
authors sequenced the human homolog of Pcdh15 in the
affected families. Affected individuals in one family pos-
sessed a putative splice-acceptor–site mutation, IVS27-
2ArG, that is predicted to lead to inclusion of sequence
from intron 27 and loss of exon 28. A second family
had an R3X nonsense mutation that should lead to com-
plete loss of the encoded protein. PCDH15 encodes pro-
tocadherin 15, a member of a family of proteins that is
believed to play a role in cell adhesion during synap-
togenesis. Alagramam et al. (see the citation in the article
by Ahmed et al.) recently showed that the Ames waltzer
mouse has abnormal stereocilia in the cochlear hair cells,
indicating that Pcdh15 is required for normal function
of the inner ear. Its precise role in this function is unclear.
SDHB Mutations in Familial Pheochromocytoma and
in Familial Paraganglioma, by Astuti et al. (p. 49)
Mutations in SDHD and SDHC are associated with he-
reditary paragangliomas, which are slow-growing tu-
mors in the extra-adrenal sympathetic ganglia. These
genes encode subunits of mitochondrial complex II, and
they anchor the SDHA and SDHB subunits of this com-
plex to the inner-mitochondrial membrane. Because of
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the interaction of these proteins to perform a common
function in cellular respiration, Astuti et al. wondered
whether SDHB mutations and additional SDHC mu-
tations could be associated with paraganglioma or with
pheochromocytoma, a related type of tumor that de-
velops in the adrenal medullary tissue. An R91X mu-
tation was found in SDHB in three families with pheo-
chromocytoma; two of these families also had at least
one case of paraganglioma. No haplotype in the SDHB
region was shared between the families, so it was be-
lieved to be a recurrent mutation. Two additional SDHB
mutations were discovered in this study: a conserved
proline was changed to arginine (P198R) in one family
with pheochromocytoma, and a c.725delC frameshift
deletion was found in one sporadic case of pheochromo-
cytoma. No SDHCmutations were found in the sample.
The process by which these mutations lead to tumori-
genesis is unclear. It has previously been suggested that
cellular proliferation may occur through a defect in ox-
ygen sensing (see the citation of Baysal et al. in the article
by Astuti et al.). Astuti et al. propose an alternative
explanation, in which tumors result from a failure of
apoptosis.
A Nonsense Mutation in MSX1 Causes Witkop
Syndrome, by Jumlongras et al. (p. 67)
Congenital absence of some permanent teeth, as well as
dysplastic finger and toenails, are symptoms of Witkop
syndrome, which is also known as “tooth and nail syn-
drome.” BecauseMSX1 mutations have previously been
associated with tooth agenesis, this gene is a plausible
candidate gene for Witkop syndrome. Markers around
the MSX1 locus show evidence of linkage to the phe-
notype in an affected family. Encouraged by this linkage,
Jumlongras et al. sequenced the coding regions and
flanking intron sequences of MSX1 and identified a
S202X nonsense mutation that cosegregated with Wit-
kop syndrome in this family.MSX1 is a homeobox gene.
The mutation, which is in the homeobox coding region,
is believed to result in haploinsufficiency, because it is
predicted to encode a protein that is completely non-
functional. It is curious that another nonsense mutation
in MSX1, S105X, which would also be predicted to re-
sult in complete loss of protein function, has been as-
sociated with oral clefting in addition to tooth agenesis.
The authors propose that the effects of modifier genes
may explain the phenotypic differences between these
families.
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Homocysteine Metabolism in Down Syndrome,
by Pogribna et al. (p. 88)
With three copies of chromosome 21, individuals with
Down syndrome are in a position to have overexpression
of many genes. This view may be oversimplistic, because
compensatory mechanisms may help to prevent the over-
expression of some genes or may provide adaptive re-
sponses to the overexpression. Pogribna et al. feel that
Down syndrome can be viewed partly as a metabolic dis-
ease due to overexpression of certain genes on chromo-
some 21. Their paper focuses on one such gene, that for
cystathionine b-synthase (CBS). Overexpression of CBS
activity has been documented in people with Down syn-
drome. CBS directs homocysteine to a cysteine and glu-
tathione synthesis pathway, thereby depriving the methi-
onine synthase reaction of its precursor, homocysteine.
Progribna et al. demonstrate, in children with Down syn-
drome, decreases in such things as total plasma homo-
cysteine, methionine, glutathione, and S-adenosylme-
thionine. Increases in cysteine, cystathione, and adenosine
are also noted. Opposite to what might have been pre-
dicted on the basis of reductions in the methylation pre-
cursors, a global increase in DNA methylation is also
observed in lymphocytes from individuals with Down
syndrome. The authors propose that decreased homo-
cysteine availability creates a functional folate deficiency
that may play a role in Down syndrome pathology. On
the basis of the demonstration of metabolite imbalances
in children with Down syndrome, the authors perform in
vitro nutrient-supplementation experiments on trisomy
21 cells, to determine whether some of these metabolites
can be normalized. The supplementation significantly al-
ters metabolite levels in the cells, allowing for the possi-
bility that nutritional intervention may have a therapeutic
effect on the metabolic pathology of Down syndrome,
although it should be stressed that the significance of these
findings in this regard are quite unclear and will require
vigorous follow-up.
A Mutation in H-Ferritin mRNA, by Kato et al.
(p. 191)
Kato et al. have identified a woman who has high serum
ferritin levels, increased serum iron and transferrin sat-
uration, and iron deposition in hepatocytes, Kupffer
cells, and macrophages. Three family members also ex-
hibited elevated serum ferritin levels, suggesting a genetic
disorder. The prevalentHFE-1 and TFR2mutations that
are normally associated with hemochromatosis were not
present in this family. However, there was a heterozygous
A49T mutation in the 5′ UTR of the H-subunit of fer-
ritin. This mutation falls in the iron-responsive element
(IRE) of this gene, which is involved in translational
control of gene expression. The mutation strengthens the
interaction between the IRE and a translational repres-
sor, thereby increasing this repression. Immunoblotting
of a liver-biopsy sample from one of the affected indi-
viduals confirms the decreased expression of the H-sub-
unit of ferritin, as well as an increase in the L-subunit
levels. Cells transfected with a construct encoding the
mutated H-subunit show increased uptake of iron but
decreased incorporation of 59Fe into ferritin. The authors
believe that this results from reductions in the ferroxi-
dase activity of the H-subunit, which are due to de-
creased production of the protein, because this activity
is essential for the incorporation of iron into ferritin.
These defects probably lead to the tissue iron deposition
seen in the affected individuals.
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